<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6410217\results\search\tropicalVirus\results.xml">
  <result pre="VirusesVirusesvirusesViruses1999-4915MDPI pmcid: 6410217 doi: 10.3390/v11020175viruses-11-00175 : Review Tropism of the" exact="Chikungunya" post="Virus https://orcid.org/0000-0002-2948-4243MatusaliGiulia*ColavitaFrancesca*BordiLiciaLalleEleonorahttps://orcid.org/0000-0002-1076-2979IppolitoGiuseppeCapobianchiMaria R.https://orcid.org/0000-0001-9819-236XCastillettiConcetta[], licia.bordi@inmi.iteleonora.lalle@inmi.itgiuseppe.ippolito@inmi.itmaria.capobianchi@inmi.itconcetta.castilletti@inmi.it *Correspondence: giulia.matusali@inmi.it (G.M.); francesca.colavita@inmi.it (F.C.)"/>
  <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Chikungunya" post="virus (CHIKV) is a re-emerging mosquito-borne virus that displays"/>
  <result pre="involving mosquito vectors and human or vertebrate animal hosts. Although" exact="CHIKV" post="was first isolated in 1953, its pathogenesis was only"/>
  <result pre="studied after its re-emergence in 2004. The unexpected spread of" exact="CHIKV" post="to novel tropical and non-tropical areas, in some instances"/>
  <result pre="agent and its associated diseases. The comprehension of the exact" exact="CHIKV" post="target cells and organs, mechanisms of pathogenesis, and spectrum"/>
  <result pre="tropism arthropod vectors animal hosts pathogenesis vertical transmission 1. Introduction" exact="Chikungunya" post="virus (CHIKV), a mosquito-borne alphavirus of the Togaviridae family,"/>
  <result pre="Culex spp. mosquitoes in 1953 [1]. In the late 1950s," exact="CHIKV" post="was described in Uganda, the sub-Saharan region, and in"/>
  <result pre="Southern Africa [2]. Based on the phylogenetic analysis of the" exact="CHIKV" post="sequences from these early African outbreaks, they were grouped"/>
  <result pre="is thought to have moved from Africa to Asia, where" exact="CHIKV" post="outbreaks were initially confused with dengue epidemics. Genetic analyses"/>
  <result pre="outbreaks were initially confused with dengue epidemics. Genetic analyses of" exact="CHIKV" post="isolated from 1958 to 1973 in Asia placed them"/>
  <result pre="large epidemic in Réunion Island in 2005 [5]. Cases of" exact="CHIKV" post="(IOL lineage) have been described in Europe since 2007,"/>
  <result pre="coming back from India [6]. Since then, autochthonous cases of" exact="CHIKV" post="fever have occurred in France, Croatia, Spain, and Italy."/>
  <result pre="in France, Croatia, Spain, and Italy. In the Pacific region," exact="CHIKV" post="(Asian lineage) was first detected in early 2011 in"/>
  <result pre="Micronesia and French Polynesia [7,8]. In the Western Hemisphere, Asian" exact="CHIKV" post="was initially identified in the Caribbean, precisely in Saint"/>
  <result pre="the ECSA isolates detected in Angola [8,9]. The most recent" exact="CHIKV" post="outbreak was reported in Sudan, affecting seven states, with"/>
  <result pre="State [10,11] (see [12] for a more extensive review on" exact="CHIKV" post="epidemics). 2. Invertebrate and Vertebrate Animal Hosts 2.1. Invetebrate"/>
  <result pre="of human diseases, and account for the vast majority of" exact="CHIKV" post="transmission to humans through the urban transmission cycle (i.e.,"/>
  <result pre="A226V E1) was considered responsible for the increased fitness of" exact="CHIKV" post="in Ae albopictus and the consequent acquisition of a"/>
  <result pre="mosquito [16,17], and allowed for the substantial geographic expansion of" exact="CHIKV" post="throughout sub-Saharan Africa and Southeast Asia, and into Europe"/>
  <result pre="Southeast Asia, and into Europe [18]. It is noteworthy that" exact="CHIKV" post="isolated from some of the European autochthonous cases lacked"/>
  <result pre="other mosquitoes have been found to be incidentally infected by" exact="CHIKV" post="in Africa, including Culex spp., Anopheles spp., and Mansonia"/>
  <result pre="Data from laboratory-based competence assays further enlarge the spectrum of" exact="CHIKV" post="potential vectors. Results from nine studies demonstrated a full"/>
  <result pre="vectors. Results from nine studies demonstrated a full competence for" exact="CHIKV" post="transmission of mosquitoes captured in Africa (Ae fulgens, Ae"/>
  <result pre="Ae notoscriptus) [33,34,35,36,37,38]. Moreover, one study demonstrated the presence of" exact="CHIKV" post="in the saliva of Culex gelidus mosquitoes after intrathoracic"/>
  <result pre="inoculation [39], while other researchers observed a low rate of" exact="CHIKV" post="transmission for Ae koreicus, a mosquito new to Europe"/>
  <result pre="mosquito vectors display different degrees of vector competence for different" exact="CHIKV" post="isolates, and the nsP3 viral protein seems to be"/>
  <result pre="protein seems to be a determinant of vector specificity [41]." exact="CHIKV" post="is horizontally transmitted to vectors during a blood meal"/>
  <result pre="vectors during a blood meal on a viremic host with" exact="CHIKV" post="viral titers ranging from 103–105 plaque-forming units per ml"/>
  <result pre="replicates. There are two mechanisms proposed for the dissemination of" exact="CHIKV" post="from the midgut to secondary organs, as follows: (i)"/>
  <result pre="abdomen to the head), eventually reaching the salivary glands [33,50]." exact="CHIKV" post="replicates and is stored in the acinar cells of"/>
  <result pre="where it apparently does not cause a cytopathic effect [51,52,53,54]." exact="CHIKV" post="infection of the fat bodies of the Aedes species,"/>
  <result pre="for other arboviruses (e.g., dengue virus 2 (DENV 2) and" exact="Zika" post="virus (ZIKV)) [49,55], is currently undetermined. On the contrary,"/>
  <result pre="isolation from the legs and wings indicate the presence of" exact="CHIKV" post="in these districts [56] (see Figure 1 for CHIKV"/>
  <result pre="of CHIKV in these districts [56] (see Figure 1 for" exact="CHIKV" post="mosquito tissue tropism). Interestingly, the ovary is also infected"/>
  <result pre="the virus persisting in eggs [62]. The transovarial transmission of" exact="CHIKV" post="through eggs potentially leads to virus survival in adverse"/>
  <result pre="desiccation during the dry season) [63,64]. On the other hand," exact="CHIKV" post="seems to perturb the egg-laying pathway—resulting in a lower"/>
  <result pre="the human population may occur. In Africa, during inter-epidemic periods," exact="CHIKV" post="is believed to be preserved via a sylvatic transmission"/>
  <result pre="the Pacific) and Europe in the amplification and survival of" exact="CHIKV" post="has been poorly investigated to date. Indeed, the majority"/>
  <result pre="(Table 1). In the early studies carried out in Senegal," exact="CHIKV" post="was isolated from non-human primates (NHPs) (i.e., Cercopithecus aethiops,"/>
  <result pre="rattus) (reviewed in [65] and [66,67,69]). Notably, neutralizing antibodies against" exact="CHIKV" post="were measured in one forest buffalo (Syncerus caffer nanus)"/>
  <result pre="one report was published on the infection and seroprevalence of" exact="CHIKV" post="in American NHPs [79]. The American study showed low"/>
  <result pre="of non-human-vertebrates’ natural infection, experimental investigations on host susceptibility to" exact="CHIKV" post="were mostly conducted in NHPs and rodents, with the"/>
  <result pre="order to assess the onset of viremia and seroconversion upon" exact="CHIKV" post="infection. The animals with detectable CHIKV viremia were some"/>
  <result pre="viremia and seroconversion upon CHIKV infection. The animals with detectable" exact="CHIKV" post="viremia were some mammals (i.e., hamsters, C57BL/6 mice, and"/>
  <result pre="birds and non-primate mammals are competent reservoirs for CHIKV. 3." exact="CHIKV" post="Cellular Receptors Viral tropism is defined as the capacity"/>
  <result pre="for viral attachment molecules being of undeniable importance [83]. The" exact="CHIKV" post="protein that facilitates cell binding is the E2 glycoprotein,"/>
  <result pre="the E2 glycoprotein, while the related cellular receptor/s crucial for" exact="CHIKV" post="entry has/have yet to be recognized [83]. Given the"/>
  <result pre="and cell types [83]. The first molecule indicated as a" exact="CHIKV" post="receptor in 2012 was Prohibitin 1 (PHB1), a multifunctional"/>
  <result pre="In microglial cells, PHB1 was shown to co-immunoprecipitate with the" exact="CHIKV" post="E2 protein, and the number of infected cells was"/>
  <result pre="entry by pre-incubating HEK-293T cells with flavaglines (prohubitin ligands) before" exact="CHIKV" post="infection. This pre-treatment reduced both the percentage of infected"/>
  <result pre="through a genome-wide screening for the cellular factors required for" exact="CHIKV" post="entry, identified the cell adhesion molecule Mxra8. They demonstrated"/>
  <result pre="molecule Mxra8. They demonstrated that blocking this molecule prior to" exact="CHIKV" post="infection significantly reduced the number of human primary synovial"/>
  <result pre="reduction .ca) [86]. In a mouse model of in vivo" exact="CHIKV" post="infection, the administration of the Mxr8a-Fc protein or blocking"/>
  <result pre="Mxr8a-Fc protein or blocking antibodies reduced both foot swelling and" exact="CHIKV" post="infection with a differential efficiency, based on treatment kinetics"/>
  <result pre="Nevertheless, the lack of Mxra8 on the membranes of some" exact="CHIKV" post="target cells (e.g., keratinocytes) indicates that this factor can"/>
  <result pre="molecules, T-cell immunoglobulin and mucin domain-1 (TIM-1), recently involved in" exact="ZIKV" post="entry, and Glycosaminoglycans (GAGs), important for the efficient infection"/>
  <result pre="and Venezuelan equine encephalitis virus (VEEV)), have been implicated in" exact="CHIKV" post="attachment (reviewed in [83]) to human cells, while HSC70"/>
  <result pre="HSC70 and ATP synthase beta subunit have been suggested as" exact="CHIKV" post="binding factors in mosquito cells [87,88]. Overall, a plethora"/>
  <result pre="plethora of cell membrane molecules have been indicated as putative" exact="CHIKV" post="binding/entry factors, but no definitive identification has been established."/>
  <result pre="been established. 4. Human Infection Following an infected mosquito bite," exact="CHIKV" post="is introduced into the human skin and into the"/>
  <result pre="or suspected (sexual transmission). 4.1. Stages and Clinical Signs of" exact="Chikungunya" post="Infection One major challenge for clinicians, nowadays, is to"/>
  <result pre="to differentiate the clinical signs of chikungunya from those of" exact="Zika" post="and dengue fever, especially when these viruses are co-circulating."/>
  <result pre="and dengue fever, especially when these viruses are co-circulating. Unlike" exact="ZIKV" post="and DENV, whose infections are asymptomatic in about 62%"/>
  <result pre="asymptomatic in about 62% and 75% of individuals, respectively [89,90]," exact="CHIKV" post="causes symptoms in a high majority (72% to 95%)"/>
  <result pre="a high majority (72% to 95%) of infected people [91,92]." exact="CHIKV" post="infects humans through the bite of Aedes spp. mosquito"/>
  <result pre="and range from photophobia to retro-orbital pain and conjunctivitis [95]." exact="Chikungunya" post="chronic disease is characterized by the persistence or relapse"/>
  <result pre="the pooled prevalence of chronic inflammatory rheumatism (CIR) associated to" exact="CHIKV" post="infection was 40.2% [98]. A growing number of atypical"/>
  <result pre="organs. Economopoulou and colleagues reported that during the large 2005–2006" exact="CHIKV" post="outbreak on the Reunion Island, the proportion of atypical"/>
  <result pre="proportion of atypical cases (defined as patients with laboratory confirmed" exact="CHIKV" post="infection and symptoms other than fever and arthralgia) was"/>
  <result pre="is important to mention the neurological complications (approximately 0.1% of" exact="CHIKV" post="infection develops neurological disorders), most commonly encephalitis and encephalopathy,"/>
  <result pre="disorders), most commonly encephalitis and encephalopathy, prompted the investigation of" exact="CHIKV" post="tropism for the central nervous system (CNS) [107]. Acute"/>
  <result pre="a variety of agents, including arboviruses, has been associated to" exact="CHIKV" post="infection [107,110,111,112]. The tropism of CHIKV in the nervous"/>
  <result pre="has been associated to CHIKV infection [107,110,111,112]. The tropism of" exact="CHIKV" post="in the nervous system will be further detailed in"/>
  <result pre="production [113], and the effect of these cytokines in controlling" exact="CHIKV" post="replication has been extensively investigated. IFN-I and IFN stimulated"/>
  <result pre="and the role of IFN-I response in the context of" exact="CHIKV" post="infection is evidenced by the full susceptibility to severe"/>
  <result pre="CHIKV infection is evidenced by the full susceptibility to severe" exact="CHIKV" post="infection of IFN-type-I receptors deficient (IFNAR -/-), in contrast"/>
  <result pre="in contrast to adult wild-type (wt) mice [115]. In vitro," exact="CHIKV" post="does not directly stimulate IFN-I production in immune cells."/>
  <result pre="the peak of IFN correlated with the decline in the" exact="CHIKV" post="load. This prompt inhibition avoided CHIKV dissemination [115]. In"/>
  <result pre="the decline in the CHIKV load. This prompt inhibition avoided" exact="CHIKV" post="dissemination [115]. In infected patients and NHPs, the viral"/>
  <result pre="This can be in part due to the counteraction of" exact="CHIKV" post="proteins. Indeed, the viral nonstructural protein 2 (nsP2) has"/>
  <result pre="production and spread [120], but in vitro experiments demonstrated that" exact="CHIKV" post="is able to hide in apoptotic blebs and infect"/>
  <result pre="tumor necrosis factor (TNFα)) in the plasma of acutely infected" exact="CHIKV" post="patients and NHPs [116,122,123,124,125,126,127]. Notably, IL-6, IL-1b, and TNFα"/>
  <result pre="other cytokines/chemokines have been indicated as forming a generic acute" exact="CHIKV" post="signature in a meta-analysis conducted in all patient cohorts"/>
  <result pre="growth factors [130]. Another factor involved in the modulation of" exact="CHIKV" post="pathogenesis is the interferon regulatory factor 1 (IRF-1), which"/>
  <result pre="regulatory factor 1 (IRF-1), which in an IFN-independent manner, restricts" exact="CHIKV" post="replication in muscle cells and contrasts the infiltration of"/>
  <result pre="tissues of mice [131]. Monocytes/macrophages also have a role in" exact="CHIKV" post="pathogenesis, both secreting inflammatory mediators, migrating to distal districts,"/>
  <result pre="4.3.4). Natural killer (NK) cells showed activated profiles during acute" exact="CHIKV" post="[132], and NK cells’ infiltration in the synovial tissue"/>
  <result pre="[129]. Adaptive immunity is mediated by B and T cells." exact="CHIKV" post="induces a robust humoral response leading to the production"/>
  <result pre="biopsy from a neonatal fatal case [142]. In these cells," exact="CHIKV" post="infection determines a strong antiviral IFN-type-I (IFN-I) response, alongside"/>
  <result pre="results were obtained by another research group, who used IOL" exact="CHIKV" post="strains encoding GFP or mCherry reporter genes to infect"/>
  <result pre="by epithelial cells). The susceptibility of primary human keratinocytes to" exact="CHIKV" post="was recently confirmed by Zhang et al. [86], where"/>
  <result pre="mouse model supports a role for these antiviral pathways in" exact="CHIKV" post="restriction. Along with the dermal fibroblasts and keratinocytes, melanocytes"/>
  <result pre="the dermal fibroblasts and keratinocytes, melanocytes are also permissive for" exact="CHIKV" post="[148], while the infection of dermal macrophages is only"/>
  <result pre="other anatomical districts has been characterized in NHP models, where" exact="CHIKV" post="travels from the site of infection (i.e., the skin)"/>
  <result pre="cells producing viral particles were primary monocyte-derived-macrophages [140]. Since then," exact="CHIKV" post="tropism for blood cells has been more extensively studied,"/>
  <result pre="(CXCL9), IL1β, and TNFα) in the plasma of acutely infected" exact="CHIKV" post="patients was found to correlate with high viral titers"/>
  <result pre="[122,123,124,125,126,127]. Similar findings in NHPs further validate these models of" exact="CHIKV" post="infection/pathogenesis [116]. Interestingly, viral replication dynamics in PBMCs experimentally"/>
  <result pre="[116]. Interestingly, viral replication dynamics in PBMCs experimentally infected with" exact="CHIKV" post="and DENV resulted in a significant reduction of CHIKV"/>
  <result pre="viral replication dynamics in PBMCs experimentally infected with CHIKV and" exact="DENV" post="resulted in a significant reduction of CHIKV progeny and"/>
  <result pre="with CHIKV and DENV resulted in a significant reduction of" exact="CHIKV" post="progeny and a moderate enhancement of DENV production. Co-infection"/>
  <result pre="significant reduction of CHIKV progeny and a moderate enhancement of" exact="DENV" post="production. Co-infection also led to higher levels of IL-6"/>
  <result pre="the two arboviral diseases [152]. The effect of co-infections on" exact="CHIKV" post="tropism and pathogenesis is ill-defined and should be further"/>
  <result pre="be further investigated both in humans and animal models. Finally," exact="CHIKV" post="can also associate to red blood cells and platelets,"/>
  <result pre="Muscle, Joint, and Bone During the acute and subacute phase," exact="CHIKV" post="reaches the muscle and joint compartments where it gives"/>
  <result pre="acutely infected and the other relapsing) were stained positive for" exact="CHIKV" post="antigens in fusiform curved shape cells co-labelling with specific"/>
  <result pre="Nevertheless, primary human myoblasts were found to be permissive to" exact="CHIKV" post="in a more recent study [156], and skeletal muscle"/>
  <result pre="antigens in a fatal neonatal case [142]. The ability of" exact="CHIKV" post="to infect progenitor cells and to induce skeletal muscle"/>
  <result pre="muscle as a site of viral persistence. The other distinctive" exact="CHIKV" post="clinical syndrome is arthralgia, which is generally of symmetric"/>
  <result pre="distal synovial joints more commonly affected than the proximal [129]." exact="CHIKV" post="RNA and proteins have been identified in the synovial"/>
  <result pre="[129,149,155,157,158], and both synovial fibroblasts and macrophages are susceptible to" exact="CHIKV" post="[86,129,142,159]. The histological analysis of a chronic patient’s biopsy"/>
  <result pre="of a chronic patient’s biopsy showed the active replication of" exact="CHIKV" post="in joint macrophages’ infiltration of activated NK cells and"/>
  <result pre="Together with joint inflammation, cartilage degradation also takes place in" exact="CHIKV" post="infected individuals. In humans, the presence of elevated levels"/>
  <result pre="collagenosis and fibrosis were observed [125,161,162]. A direct effect of" exact="CHIKV" post="on cartilage is suggested by viral replication in human"/>
  <result pre="by viral replication in human primary chondrocytes [86] and in" exact="CHIKV" post="inoculated immunodeficient (IRF3/7−/−) mice [145]. Bone loss is another"/>
  <result pre="immunodeficient (IRF3/7−/−) mice [145]. Bone loss is another hallmark of" exact="CHIKV" post="arthritis, and osteoblasts are a site of CHIKV replication"/>
  <result pre="hallmark of CHIKV arthritis, and osteoblasts are a site of" exact="CHIKV" post="replication and persistence [86,163,164,165]. Ex vivo infection of human"/>
  <result pre="joints (CCL2, CCL7, and CCL8) and in the serum of" exact="CHIKV" post="patients (CCL2) [122,123,129,165] favors an osteoclastogenic and chemo-attractive microenvironment."/>
  <result pre="CHIKV-infected animals [125,166,167], and by the ability of supernatants of" exact="CHIKV" post="infected synovial fibroblasts to induce migration and differentiation into"/>
  <result pre="the clearance of the virus [167] (see Figure 2 for" exact="CHIKV" post="tropism in muscle, joint, and bone). 4.3.3. Infection of"/>
  <result pre="muscle, joint, and bone). 4.3.3. Infection of the Nervous System" exact="CHIKV" post="is not considered to be a true neurotropic virus"/>
  <result pre="in the 1960s and 1970s [168,169,170]. Upon the re-emergence of" exact="CHIKV" post="in the Indian Ocean in 2005, a growing number"/>
  <result pre="few brain autopsies analyzed for histopathological studies, the presence of" exact="CHIKV" post="antigens was not evaluated [171]. As a consequence, the"/>
  <result pre="not evaluated [171]. As a consequence, the target cells of" exact="CHIKV" post="in the human brain remain unknown. Nevertheless, the in"/>
  <result pre="and microglial cells [176,177] to CHIKV. The apoptosis observed in" exact="CHIKV" post="infected neuroblastoma cells and astrocytes suggests a direct implication"/>
  <result pre="infection of oligodendrocytes was evidenced in vitro [178,179,180]. In NHPs," exact="CHIKV" post="RNA was detected in the brain during the acute"/>
  <result pre="of human and animal origin can, in some instances, produce" exact="CHIKV" post="infective particles [140,181,182]. The mechanisms by which CHIKV affects"/>
  <result pre="instances, produce CHIKV infective particles [140,181,182]. The mechanisms by which" exact="CHIKV" post="affects the human nervous system remain ill defined. It"/>
  <result pre="In the nervous system, the eye may be injured in" exact="CHIKV" post="patients. Ocular diseases present mainly as retro-orbital pain or"/>
  <result pre="mainly as retro-orbital pain or conjunctivitis at the time of" exact="CHIKV" post="systemic illness, and predominantly as uveitis, retinitis, or optic"/>
  <result pre="reported three times [187,188,189], and in a laboratory screening of" exact="CHIKV" post="infection of corneal donors, infectious viral particles and RNA"/>
  <result pre="the eye tissue from four donors [189]. The characterization of" exact="CHIKV" post="positive cells in the human eye revealed the infection"/>
  <result pre="muscle fibers [189]. Based on these results, the risk of" exact="CHIKV" post="iatrogenic transmission through corneal transplantation must be taken into"/>
  <result pre="Target Organs The wide range of secondary organs targeted by" exact="CHIKV" post="may explain the rare consequences of chikungunya infection, and"/>
  <result pre="was developed by Labadie and coworkers [166], who inoculated a" exact="CHIKV" post="IOL isolate into 15 cynomolgus macaques (Macaca fascicularis). High"/>
  <result pre="liver, and heart have been found to be positive for" exact="CHIKV" post="in another NHP model [190], and viral RNA has"/>
  <result pre="findings suggest that kidneys and lungs are also targeted by" exact="CHIKV" post="[140,177,190,192]. Both human and animal derived kidney epithelial and"/>
  <result pre="for viral assays [140,177,192]. Nevertheless, the exact target cells of" exact="CHIKV" post="in human secondary target organs (e.g., the kidney, liver,"/>
  <result pre="fluid specimens such as saliva and urine. In the saliva," exact="CHIKV" post="seems to originate from oral bleeding [193], while whether"/>
  <result pre="2017, we screened 1414 serum specimens for the presence of" exact="CHIKV" post="RNA, and 196 of these resulted positive. For some"/>
  <result pre="Target Organs upon Non-Arthropod-Borne Transmission Cases of mother to child" exact="CHIKV" post="transmission have been reported, and a recent systematic review"/>
  <result pre="fetuses [198]. In a cohort study from the same epidemics," exact="CHIKV" post="RNA was again detected in the amniotic fluid (4/23"/>
  <result pre="(19/462) [199], and a fatal Brazilian fetal case of the" exact="Zika" post="virus and CHIKV co-infection presented with CHIV RNA in"/>
  <result pre="a fatal Brazilian fetal case of the Zika virus and" exact="CHIKV" post="co-infection presented with CHIV RNA in the placenta [200]."/>
  <result pre="to infection in vitro [142,201]. Nowadays, the hypothesized mechanism of" exact="CHIKV" post="vertical transmission is the passage of the virus from"/>
  <result pre="knock-out mouse model [142]. However, recent research showed in vitro" exact="CHIKV" post="replication in human fetal membranes (from the second trimester),"/>
  <result pre="dissect the mechanisms and to reveal the risk factors of" exact="CHIKV" post="mother to child transmission. Another non-arthropod-borne route under investigation"/>
  <result pre="is the sexually driven spreading. Indeed, since the discovery of" exact="ZIKV" post="sexual transmission, great efforts have been made to understand"/>
  <result pre="tract, and whether they can be passed through sexual intercourse." exact="CHIKV" post="RNA was detected in the seminal fluid of one"/>
  <result pre="symptoms [203]. To our knowledge, together with the detection of" exact="CHIKV" post="RNA in the CVF, which we show in Table"/>
  <result pre="in Table 2, these are the only reported cases of" exact="CHIKV" post="detection in genital fluids, and the tropism of the"/>
  <result pre="investigated. 4.4. Preventive and Therapeutic Strategies Despite the fact that" exact="CHIKV" post="causes disease around the globe, with a significant impact"/>
  <result pre="in the case of severe and persistent joint pain) [204]." exact="CHIKV" post="infection may not always present specific manifestations, and it"/>
  <result pre="it may co-exist with other infectious diseases, like dengue or" exact="Zika" post="fever [205]. Thus, careful clinical management in the absence"/>
  <result pre="and the increased risk of bleeding manifestations in cases of" exact="DENV" post="(co-)infection [206]. To find an effective treatment for CHIKV,"/>
  <result pre="IFN-α, and Sofosbuvir, may have a positive effect in controlling" exact="CHIKV" post="replication [8,207,208,209,210]. Chloroquine (CQ), a common antimalarial medicine, was"/>
  <result pre="medicine, was widely used to treat rheumatoid arthritis-like symptoms, following" exact="CHIKV" post="infection during the Reunion Island outbreak [204,211]. Although CQ"/>
  <result pre="infection during the Reunion Island outbreak [204,211]. Although CQ inhibits" exact="CHIKV" post="replication in vitro [212,213], it showed no or a"/>
  <result pre="vitro [212,213], it showed no or a moderate effect on" exact="CHIKV" post="acute and chronic symptoms in humans [211,214], and in"/>
  <result pre="in humans [211,214], and in NHPs, it even determined enhanced" exact="CHIKV" post="replication and delayed cellular and humoral response [214]. Immunotherapy"/>
  <result pre="points after infection [208,215]. Because of the limited diversity between" exact="CHIKV" post="strains, vaccine strategy represents the best preventive measure to"/>
  <result pre="been developed and tested [216]. TSI-GSD-218 was the first live-attenuated" exact="CHIKV" post="vaccine reported in trial, and was made using CHIK"/>
  <result pre="on cDNA expression plasmid transfected into human cells, and containing" exact="CHIKV" post="structural proteins), and the viral vectored vaccines (VVV), which"/>
  <result pre="lethality (RIDL), and Wolbachia-infected males) [220]. 5. Conclusions Before 2004," exact="CHIKV" post="caused small outbreaks in confined regions within Africa and"/>
  <result pre="better characterized, and several syndromes have been newly associated to" exact="CHIKV" post="infection. The expansion to novel regions and the drastic"/>
  <result pre="by ex vivo findings. Nevertheless, the exact cellular receptors for" exact="CHIKV" post="need to be definitively established. At the tissue level,"/>
  <result pre="CHIKV need to be definitively established. At the tissue level," exact="CHIKV" post="is amplified at the site of infection, the skin,"/>
  <result pre="the skeletal muscle and the synovial joints. At these sites," exact="CHIKV" post="may persist for several months, giving rise to chronic"/>
  <result pre="of the inflammatory pathways triggered by the virus. Moreover, as" exact="CHIKV" post="is often co-circulating with other arthropod-borne pathogens, it is"/>
  <result pre="properties and relationship to the epidemicJ. Hyg.19565417719110.1017/S002217240004444213346078 2.WeinbrenM.P.The occurrence of" exact="Chikungunya" post="virus in Uganda. II. In man on the Entebbe"/>
  <result pre="distant evolutionary relationshipsJ. Gen. Virol.20008147147910.1099/0022-1317-81-2-47110644846 4.VolkS.M.ChenR.TsetsarkinK.A.AdamsA.P.GarciaT.I.SallA.A.NasarF.SchuhA.J.HolmesE.C.HiggsS.et al.Genome-Scale Phylogenetic Analyses of" exact="Chikungunya" post="Virus Reveal Independent Emergences of Recent Epidemics and Various"/>
  <result pre="Epidemics and Various Evolutionary RatesJ. Virol.2010846497650410.1128/JVI.01603-0920410280 5.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.-C.LavenirR.PardigonN.ReynesJ.-M.PettinelliF.et al.Genome Microevolution of" exact="Chikungunya" post="Viruses Causing the Indian Ocean OutbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 6.RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA.PanningM.CordioliP.FortunaC.BorosS.MaguranoF.et al.Infection"/>
  <result pre="Silva AzevedoR.D.S.da SilvaD.E.A.da SilvaE.V.P.et al.Emergence and potential for spread of" exact="Chikungunya" post="virus in BrazilBMC Med.20151310210.1186/s12916-015-0348-x25976325 10.MohamedN.MagzoubM.MohamedR.E.H.AleanizyF.S.AlqahtaniF.Y.NourB.Y.M.AlkarsanyM.M.S.Prevalence and identification of arthropod-"/>
  <result pre="of Aedes (Stegomyia) hensilli Farner as an epidemic vector of" exact="Chikungunya" post="virus on Yap Island, Federated States of Micronesia, 2013Am."/>
  <result pre="therapyAntiviral Res.20139934537010.1016/j.antiviral.2013.06.00923811281 19.Vega-RuaA.ZouacheK.CaroV.DiancourtL.DelaunayP.GrandadamM.FaillouxA.-B.High Efficiency of Temperate Aedes albopictus to Transmit" exact="Chikungunya" post="and Dengue Viruses in the Southeast of FrancePLoS ONE20138e5971610.1371/journal.pone.005971623527259"/>
  <result pre="19.Vega-RuaA.ZouacheK.CaroV.DiancourtL.DelaunayP.GrandadamM.FaillouxA.-B.High Efficiency of Temperate Aedes albopictus to Transmit Chikungunya and" exact="Dengue" post="Viruses in the Southeast of FrancePLoS ONE20138e5971610.1371/journal.pone.005971623527259 20.GrandadamM.CaroV.PlumetS.ThibergeJ.-M.SouarèsY.FaillouxA.-B.TolouH.J.BudelotM.CosseratD.Leparc-GoffartI.et al.Chikungunya"/>
  <result pre="Infect. Dis.20182417818010.3201/eid2401.171605 22.TsetsarkinK.A.WeaverS.C.Sequential Adaptive Mutations Enhance Efficient Vector Switching by" exact="Chikungunya" post="Virus and Its Epidemic EmergencePLoS Pathog.20117e100241210.1371/journal.ppat.100241222174678 23.TsetsarkinK.A.ChenR.YunR.RossiS.L.PlanteK.S.GuerboisM.ForresterN.PerngG.C.SreekumarE.LealG.et al.Multi-peaked adaptive"/>
  <result pre="mosquitoesNat. Commun.20145408410.1038/ncomms508424933611 24.Arias-GoetaC.MoussonL.RougeonF.FaillouxA.B.Dissemination and Transmission of the E1-226V Variant of" exact="Chikungunya" post="Virus in Aedes albopictus Are Controlled at the Midgut"/>
  <result pre="with chikungunya virusTrans. R. Soc. Trop. Med. Hyg.198175151910.1016/0035-9203(81)90005-56115488 27.DialloM.ThonnonJ.Traore-lamizanaM.FontenilleD.Vectors of" exact="Chikungunya" post="virus in Senegal: Current data and transmission cyclesAm. J."/>
  <result pre="relation to the epidemicAnn. Trop. Med. Parasitol.196458455110.1080/00034983.1964.1168621314147664 29.WeinbrenM.P.HaddowA.J.WilliamsM.C.The occurrence of" exact="Chikungunya" post="virus in Uganda. I. Isolation from mosquitoesTrans. R. Soc."/>
  <result pre="Isolation from mosquitoesTrans. R. Soc. Trop. Med. Hyg.19585225325710.1016/0035-9203(58)90084-113556869 30.DialloD.DiaI.DiagneC.T.GayeA.DialloM.Emergences of" exact="Chikungunya" post="and Zika in AfricaChikungunya and Zika VirusesHiggsS.VanlandinghamD.L.PowersA.M.ElsevierAmsterdam, The Netherlands2018871339780128118658"/>
  <result pre="mosquitoesTrans. R. Soc. Trop. Med. Hyg.19585225325710.1016/0035-9203(58)90084-113556869 30.DialloD.DiaI.DiagneC.T.GayeA.DialloM.Emergences of Chikungunya and" exact="Zika" post="in AfricaChikungunya and Zika VirusesHiggsS.VanlandinghamD.L.PowersA.M.ElsevierAmsterdam, The Netherlands2018871339780128118658 31.BrèsP.CamicasJ.L.CornetM.RobinY.TauffliebR.Epidemiology of"/>
  <result pre="Med. Hyg.19585225325710.1016/0035-9203(58)90084-113556869 30.DialloD.DiaI.DiagneC.T.GayeA.DialloM.Emergences of Chikungunya and Zika in AfricaChikungunya and" exact="Zika" post="VirusesHiggsS.VanlandinghamD.L.PowersA.M.ElsevierAmsterdam, The Netherlands2018871339780128118658 31.BrèsP.CamicasJ.L.CornetM.RobinY.TauffliebR.Epidemiology of arbovirus diseases in SenegalBull."/>
  <result pre="Aedes aegypti and Aedes polynesiensis Populations from French Polynesia for" exact="Chikungunya" post="VirusPLoS Negl. Trop. Dis.201610e000469410.1371/journal.pntd.000469427144888 36.MendenhallI.H.ManuelM.MoorthyM.LeeT.T.M.LowD.H.W.MisséD.GublerD.J.EllisB.R.OoiE.E.PomponJ.Peridomestic Aedes malayensis and Aedes"/>
  <result pre="Trop. Dis.20171111110.1371/journal.pntd.000569828662031 38.van den HurkA.F.Hall-MendelinS.PykeA.T.SmithG.A.MackenzieJ.S.Vector Competence of Australian Mosquitoes for" exact="Chikungunya" post="VirusVector-Borne Zoonotic Dis.20101048949510.1089/vbz.2009.010619877822 39.SudeepA.B.GhodkeY.S.GeorgeR.P.IngaleV.S.DhaigudeS.D.GokhaleM.D.Vectorial capacity of Culex gelidus (Theobald)"/>
  <result pre="Cellular Factors and Functions in Mediating the Infectious entry of" exact="Chikungunya" post="VirusPLoS Negl. Trop. Dis.20137e205010.1371/journal.pntd.000205023409203 44.DongS.BalaramanV.KantorA.M.LinJ.GrantD.A.G.HeldN.L.FranzA.W.E.Chikungunya virus dissemination from the"/>
  <result pre="orally infected Aedes aegypti mosquitoesBMC Microbiol.20077910.1186/1471-2180-7-917263893 50.ZieglerS.A.NuckolsJ.McGeeC.E.HuangY.S.VanlandinghamD.L.TeshR.B.HiggsS.In Vivo Imaging of" exact="Chikungunya" post="Virus in Mice and Aedes Mosquitoes Using a Renilla"/>
  <result pre="Body Organ Culture System in Aedes Aegypti, a Vector of" exact="Zika" post="VirusJ. Vis. Exp.201710.3791/5550828872112 56.WongH.V.ChanY.F.SamI.-C.SulaimanW.Y.W.VythilingamI.Chikungunya Virus Infection of Aedes MosquitoesChikungunya"/>
  <result pre="57.SirisenaP.D.N.N.KumarA.SunilS.Evaluation of Aedes aegypti (Diptera: Culicidae) Life Table Attributes Upon" exact="Chikungunya" post="Virus Replication Reveals Impact on Egg-Laying PathwaysJ. Med. Entomol.2018551580158710.1093/jme/tjy09729931258"/>
  <result pre="of Experimental Vertical Transmission of Emerging Novel ECSA Genotype of" exact="Chikungunya" post="Virus in Aedes aegyptiPLoS Negl. Trop. Dis.20148e299010.1371/journal.pntd.000299025080107 62.WongH.V.VythilingamI.SulaimanW.Y.W.LullaA.MeritsA.ChanY.F.SamI.C.Detection of"/>
  <result pre="Trop. Med. Hyg.2017971399140410.4269/ajtmh.17-012629016323 68.OsterriethP.RatheE.Deleplanque-LiegeoisP.[Simultaneous isolation of the yellow fever and" exact="Chikungunya" post="viruses at Bili (Haut-Uele, Belgian Congo)]Ann. la Soc. Belge"/>
  <result pre="virus in macaques, MalaysiaEmerg. Infect. Dis.2015211683168510.3201/eid2109.15043926291585 75.NakgoiK.NitatpattanaN.WajjwalkuW.PongsopawijitP.KaewchotS.YoksanS.SiripolwatV.SourisM.GonzalezJ.P.Dengue, Japanese encephalitis and" exact="Chikungunya" post="virus antibody prevalence among captive monkey (Macaca nemestrina) colonies"/>
  <result pre="Evidence for Infection of Urban and Peri-urban Nonhuman Primates with" exact="Zika" post="and Chikungunya Viruses in BrazilmSphere20183e00523-1710.1128/mSphere.00523-1729404420 80.Bosco-LauthA.M.HartwigA.E.BowenR.A.Reptiles and amphibians as"/>
  <result pre="Infection of Urban and Peri-urban Nonhuman Primates with Zika and" exact="Chikungunya" post="Viruses in BrazilmSphere20183e00523-1710.1128/mSphere.00523-1729404420 80.Bosco-LauthA.M.HartwigA.E.BowenR.A.Reptiles and amphibians as potential reservoir"/>
  <result pre="infection with chikungunya virusesAm. J. Trop. Med. Hyg.20169450450610.4269/ajtmh.15-069626666699 82.McIntoshB.M.Antibody against" exact="Chikungunya" post="virus in wild primates in Southern AfricaS. Afr. J."/>
  <result pre="binding to membrane fusionViruses201573647367410.3390/v707279226198242 84.WintachaiP.WikanN.KuadkitkanA.JaimipukT.UbolS.PulmanausahakulR.AuewarakulP.KasinrerkW.WengW.Y.PanyasrivanitM.et al.Identification of prohibitin as a" exact="Chikungunya" post="virus receptor proteinJ. Med. Virol.2012841757177010.1002/jmv.2340322997079 85.WintachaiP.ThuaudF.BasmadjianC.RoytrakulS.UbolS.DésaubryL.SmithD.R.Assessment of flavaglines as"/>
  <result pre="chikungunya virus entry into insect cellsArch. Virol.20141593353336410.1007/s00705-014-2210-425168043 89.HabyM.M.PinartM.EliasV.ReveizL.Prevalence of asymptomatic" exact="Zika" post="virus infection: A systematic reviewBull. World Health Organ.20189640210.2471/BLT.17.20154129904223 90.BhattS.GethingP.W.BradyO.J.MessinaJ.P.FarlowA.W.MoyesC.L.DrakeJ.M.BrownsteinJ.S.HoenA.G.SankohO.et"/>
  <result pre="al.The global distribution and burden of dengueNature201349650450710.1038/nature1206023563266 91.AyuS.M.LaiL.R.ChanY.F.HatimA.HairiN.N.AyobA.SamI.-C.Seroprevalence survey of" exact="Chikungunya" post="virus in Bagan Panchor, MalaysiaAm. J. Trop. Med. Hyg.2010831245124810.4269/ajtmh.2010.10-027921118929"/>
  <result pre="February 2019) 94.RahmanM.JakariaS.K.SayedB.KabirA.K.M.H.MallikU.HasanR.SiddiqueA.B.HossainA.UddinN.HassanM.et al.Clinical and Laboratory Characteristics of an Acute" exact="Chikungunya" post="Outbreak in Bangladesh in 2017Am. J. Trop. Med. Hyg.201910040541010.4269/ajtmh.18-063630526743"/>
  <result pre="Inflammatory Arthritis: A Systematic Review and Meta-AnalysisArthritis Care Res.2016681849185810.1002/acr.2290027015439 99.EconomopoulouA.DominguezM.HelynckB.SissokoD.WichmannO.QuenelP.GermonneauP.QuatresousI.Atypical" exact="Chikungunya" post="virus infections: Clinical manifestations, mortality and risk factors for"/>
  <result pre="of IL-6 and Type-I IFN in a Lethal Case of" exact="Chikungunya" post="Virus Infection in an Elderly Man During the 2017"/>
  <result pre="A case seriesPediatr. Dermatol.20183539239610.1111/pde.1345029573443 106.DuttaP.SharmaA.A case of atypical ophthalmoplegia after" exact="Chikungunya" post="feverInt. Ophthalmol.20183883783910.1007/s10792-017-0529-z28397145 107.MehtaR.GerardinP.de BritoC.A.A.SoaresC.N.FerreiraM.L.B.SolomonT.The neurological complications of chikungunya virus:"/>
  <result pre="chikungunya virus: A systematic reviewRev. Med. Virol.201828e197810.1002/rmv.197829671914 108.ShardaM.MeenaH.Neurological complications in" exact="Chikungunya" post="feverJ. Assoc. Phys. India200755765769 109.SinghS.S.ManimundaS.P.SugunanA.P.VijayachariP.Four cases of acute flaccid"/>
  <result pre="Microbiol.201781610.3389/fmicb.2017.0004228197127 112.MehtaR.SoaresC.N.Medialdea-CarreraR.EllulM.da SilvaM.T.T.Rosala-HallasA.JardimM.R.BurnsideG.PamplonaL.BhojakM.et al.The spectrum of neurological disease associated with" exact="Zika" post="and chikungunya viruses in adults in Rio de Janeiro,"/>
  <result pre="action on nonhematopoietic cellsJ. Exp. Med.201020742944210.1084/jem.2009085120123960 116.BroeckelR.HaeseN.MessaoudiI.StreblowD.Nonhuman Primate Models of" exact="Chikungunya" post="Virus Infection and Disease (CHIKV NHP Model)Pathogens2015466268110.3390/pathogens403066226389957 117.FrosJ.J.LiuW.J.ProwN.A.GeertsemaC.LigtenbergM.VanlandinghamD.L.SchnettlerE.VlakJ.M.SuhrbierA.KhromykhA.A.et al.Chikungunya"/>
  <result pre="118.JonesP.H.MaricM.MadisonM.N.MauryW.RollerR.J.OkeomaC.M.BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by" exact="CHIKV" post="non-structural protein 1 (nsP1)Virology2013438374910.1016/j.virol.2013.01.01023411007 119.ColavitaF.MusumeciG.CagliotiC.Human osteoblast-like cells are permissive"/>
  <result pre="non-structural protein 1 (nsP1)Virology2013438374910.1016/j.virol.2013.01.01023411007 119.ColavitaF.MusumeciG.CagliotiC.Human osteoblast-like cells are permissive for" exact="Zika" post="virus replicationJ. Rheumatol.20184544310.3899/jrheum.17083529496921 120.KvansakulM.Viral Infection and ApoptosisViruses2017935610.3390/v912035629168732 121.Krejbich-TrototP.DenizotM.HoarauJ.-J.Jaffar-BandjeeM.-C.DasT.GasqueP.Chikungunya virus"/>
  <result pre="invade host cell defensesFASEB J.20112531432510.1096/fj.10-16417820881210 122.ChowA.HerZ.OngE.K.S.ChenJ.M.DimatatacF.KwekD.J.C.BarkhamT.YangH.RéniaL.LeoY.S.et al.Persistent arthralgia induced by" exact="Chikungunya" post="virus infection is associated with interleukin-6 and granulocyte macrophage"/>
  <result pre="factorJ. Infect. Dis.201120314915710.1093/infdis/jiq04221288813 123.KelvinA.A.BannerD.SilviG.MoroM.L.SpataroN.GaibaniP.CavriniF.PierroA.RossiniG.CameronM.J.et al.Inflammatory Cytokine Expression Is Associated with" exact="Chikungunya" post="Virus Resolution and Symptom SeverityPLoS Negl. Trop. Dis.20115e127910.1371/journal.pntd.000127921858242 124.MichlmayrD.PakT.R.RahmanA.H.AmirE.D.KimE.Kim-SchulzeS.SuprunM.StewartM.G.ThomasG.P.BalmasedaA.et"/>
  <result pre="al.Multiple Immune Factors Are Involved in Controlling Acute and Chronic" exact="Chikungunya" post="Virus InfectionPLoS Negl. Trop. Dis.20148e335410.1371/journal.pntd.000335425474568 126.ReddyV.ManiR.S.DesaiA.RaviV.Correlation of plasma viral"/>
  <result pre="Trop. Dis.20148e335410.1371/journal.pntd.000335425474568 126.ReddyV.ManiR.S.DesaiA.RaviV.Correlation of plasma viral loads and presence of" exact="Chikungunya" post="IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus"/>
  <result pre="presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute" exact="Chikungunya" post="virus infectionJ. Med. Virol.2014861393140110.1002/jmv.2387524523146 127.VenugopalanA.GhorpadeR.P.ChopraA.Cytokines in Acute ChikungunyaPLoS ONE20149e11130510.1371/journal.pone.011130525343623"/>
  <result pre="ChikungunyaPLoS ONE20149e11130510.1371/journal.pone.011130525343623 128.NgL.F.P.ChowA.SunY.-J.KwekD.J.C.LimP.-L.DimatatacF.NgL.-C.OoiE.-E.ChooK.-H.HerZ.et al.IL-1β, IL-6, and RANTES as Biomarkers of" exact="Chikungunya" post="SeverityPLoS ONE20094e426110.1371/journal.pone.000426119156204 129.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.DenizotM.GuichardE.RiberaA.HenniT.et al.Persistent Chronic Inflammation and"/>
  <result pre="ONE20094e426110.1371/journal.pone.000426119156204 129.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.DenizotM.GuichardE.RiberaA.HenniT.et al.Persistent Chronic Inflammation and Infection by" exact="Chikungunya" post="Arthritogenic Alphavirus in Spite of a Robust Host Immune"/>
  <result pre="130.TengT.-S.KamY.-W.LeeB.HapuarachchiH.C.WimalA.NgL.-C.NgL.F.P.A Systematic Meta-analysis of Immune Signatures in Patients With Acute" exact="Chikungunya" post="Virus InfectionJ. Infect. Dis.20152111925193510.1093/infdis/jiv04925635123 131.NairS.PoddarS.ShimakR.M.DiamondM.S.Interferon Regulatory Factor 1 Protects"/>
  <result pre="Virus InfectionJ. Infect. Dis.20152111925193510.1093/infdis/jiv04925635123 131.NairS.PoddarS.ShimakR.M.DiamondM.S.Interferon Regulatory Factor 1 Protects against" exact="Chikungunya" post="Virus-Induced Immunopathology by Restricting Infection in Muscle CellsJ. Virol.20179110.1128/JVI.01419-17"/>
  <result pre="of chikungunya pathogenesisAntiviral Res.201512016517410.1016/j.antiviral.2015.06.00926092642 134.HawmanD.W.StoermerK.A.MontgomeryS.A.PalP.OkoL.DiamondM.S.MorrisonT.E.Chronic Joint Disease Caused by Persistent" exact="Chikungunya" post="Virus Infection Is Controlled by the Adaptive Immune ResponseJ."/>
  <result pre="ResponseJ. Virol.201387138781388810.1128/JVI.02666-1324131709 135.TeoT.-H.LumF.-M.ClaserC.LullaV.LullaA.MeritsA.ReniaL.NgL.F.P.A Pathogenic Role for CD4+ T Cells during" exact="Chikungunya" post="Virus Infection in MiceJ. Immunol.201319025926910.4049/jimmunol.120217723209328 136.PartidosC.D.WegerJ.BrewooJ.SeymourR.BorlandE.M.LedermannJ.P.PowersA.M.WeaverS.C.StinchcombD.T.OsorioJ.E.Probing the attenuation and"/>
  <result pre="with compromised interferon (IFN) signalingVaccine2011293067307310.1016/j.vaccine.2011.01.07621300099 137.MallilankaramanK.ShedlockD.J.BaoH.KawalekarO.U.FagoneP.RamanathanA.A.FerraroB.StabenowJ.VijayachariP.SundaramS.G.et al.A DNA Vaccine against" exact="Chikungunya" post="Virus Is Protective in Mice and Induces Neutralizing Antibodies"/>
  <result pre="Trop. Dis.20137e234310.1371/journal.pntd.000234323936572 139.EkchariyawatP.HamelR.BernardE.WichitS.SurasombatpattanaP.TalignaniL.ThomasF.ChoumetV.YsselH.DesprèsP.et al.Inflammasome signaling pathways exert antiviral effect against" exact="Chikungunya" post="virus in human dermal fibroblastsInfect. Genet. Evol.20153240140810.1016/j.meegid.2015.03.02525847693 140.SourisseauM.SchilteC.CasartelliN.TrouilletC.Guivel-BenhassineF.RudnickaD.Sol-FoulonN.Le RouxK.PrevostM.C.FsihiH.et"/>
  <result pre="stepVirology201547611010.1016/j.virol.2014.11.01325496825 145.RuddP.A.WilsonJ.GardnerJ.LarcherT.BabaritC.LeT.T.AnrakuI.KumagaiY.LooY.-M.GaleM.et al.Interferon Response Factors 3 and 7 Protect against" exact="Chikungunya" post="Virus Hemorrhagic Fever and ShockJ. Virol.2012869888989810.1128/JVI.00956-1222761364 146.HondaK.YanaiH.NegishiH.AsagiriM.SatoM.MizutaniT.ShimadaN.OhbaY.TakaokaA.YoshidaN.et al.IRF-7 is"/>
  <result pre="Infect. Dis.2006121493149910.3201/eid1210.06061017176562 150.HerZ.MalleretB.ChanM.OngE.K.S.WongS.C.KwekD.J.C.TolouH.LinR.T.P.TambyahP.A.ReniaL.et al.Active Infection of Human Blood Monocytes by" exact="Chikungunya" post="Virus Triggers an Innate Immune ResponseJ. Immunol.20101845903591310.4049/jimmunol.090418120404274 151.Ruiz SilvaM.Van"/>
  <result pre="treated with amotosalen/ultraviolet A light or amustaline/glutathioneTransfusion20185874875710.1111/trf.1444229322519 154.TsetsarkinK.A.Sampson-JohannesA.SawyerL.KinseyJ.HiggsS.VanlandinghamD.L.Photochemical Inactivation of" exact="Chikungunya" post="Virus in Human Apheresis Platelet Components by Amotosalen and"/>
  <result pre="155.OzdenS.HuerreM.RiviereJ.P.CoffeyL.L.AfonsoP.V.MoulyV.de MonredonJ.RogerJ.C.El AmraniM.YvinJ.L.et al.Human Muscle Satellite Cells as Targets of" exact="Chikungunya" post="Virus InfectionPLoS ONE20072e52710.1371/journal.pone.000052717565380 156.LohachanakulJ.PhukliaW.ThannagithM.ThongsakulprasertT.SmithD.R.UbolS.Differences in response of primary human"/>
  <result pre="primary human myoblasts to infection with recent epidemic strains of" exact="Chikungunya" post="virus isolated from patients with and without myalgiaJ. Med."/>
  <result pre="Infect. Dis.201220645545710.1093/infdis/jis36822634878 164.GoupilB.A.McNultyM.A.MartinM.J.McCrackenM.K.ChristoffersonR.C.MoresC.N.Novel Lesions of Bones and Joints Associated with" exact="Chikungunya" post="Virus Infection in Two Mouse Models of Disease: New"/>
  <result pre="Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by" exact="Chikungunya" post="Virus InfectionJ. Virol.20158958159310.1128/JVI.02034-1425339772 166.LabadieK.LarcherT.JoubertC.ManniouiA.DelacheB.BrochardP.GuigandL.DubreilL.LebonP.VerrierB.et al.Chikungunya disease in nonhuman primates"/>
  <result pre="MiceJ. Virol.2010848021803210.1128/JVI.02603-0920519386 168.MazaudR.SalaünJ.J.MontaboneH.GoubeP.BazillioR.Acute neurologic and sensorial disorders in dengue and" exact="Chikungunya" post="feverBull. Soc. Pathol. Exot. Filiales19716422305109175 169.ArpinoC.CuratoloP.RezzaG.Chikungunya and the nervous"/>
  <result pre="and 1 case with autopsy findingsAm. J. Neuroradiol.2008291636163710.3174/ajnr.A113318566010 172.DhanwaniR.KhanM.BhaskarA.S.B.SinghR.PatroI.K.RaoP.V.L.ParidaM.M.Characterization of" exact="Chikungunya" post="virus infection in human neuroblastoma SH-SY5Y cells: Role of"/>
  <result pre="re-emerging arbovirusVirology200939318319710.1016/j.virol.2009.07.02419732931 174.AbrahamR.MudaliarP.PadmanabhanA.SreekumarE.Induction of Cytopathogenicity in Human Glioblastoma Cells by" exact="Chikungunya" post="VirusPLoS ONE20138e7585410.1371/journal.pone.007585424086645 175.AbrahamR.SinghS.NairS.R.HulyalkarN.V.SurendranA.JaleelA.SreekumarE.Nucleophosmin (NPM1)/B23 in the Proteome of Human"/>
  <result pre="175.AbrahamR.SinghS.NairS.R.HulyalkarN.V.SurendranA.JaleelA.SreekumarE.Nucleophosmin (NPM1)/B23 in the Proteome of Human Astrocytic Cells Restricts" exact="Chikungunya" post="Virus ReplicationJ. Proteome Res.2017164144415510.1021/acs.jproteome.7b0051328959884 176.AbereB.WikanN.UbolS.AuewarakulP.PaemaneeA.KittisenachaiS.RoytrakulS.SmithD.R.Proteomic analysis of chikungunya virus"/>
  <result pre="responses engaged by astrocytes, microglia and resident dendritic cells against" exact="Chikungunya" post="neuroinfectionJ. Gen. Virol.20159629431010.1099/vir.0.071175-025351727 180.FraisierC.KorakaP.BelghaziM.BakliM.GranjeaudS.PophillatM.LimS.M.OsterhausA.MartinaB.CamoinL.et al.Kinetic Analysis of Mouse Brain"/>
  <result pre="Virol.20159629431010.1099/vir.0.071175-025351727 180.FraisierC.KorakaP.BelghaziM.BakliM.GranjeaudS.PophillatM.LimS.M.OsterhausA.MartinaB.CamoinL.et al.Kinetic Analysis of Mouse Brain Proteome Alterations Following" exact="Chikungunya" post="Virus Infection before and after Appearance of Clinical SymptomsPLoS"/>
  <result pre="Appearance of Clinical SymptomsPLoS ONE20149e9139710.1371/journal.pone.009139724618821 181.LimP.J.ChuJ.J.H.A Polarized Cell Model for" exact="Chikungunya" post="Virus Infection: Entry and Egress of Virus Occurs at"/>
  <result pre="185.SalceanuS.O.RamanV.Recurrent chikungunya retinitisBMJ Case Rep.2018201810.1136/bcr-2017-22286430150331 186.Ulloa-PadillaJ.P.DavilaP.J.IzquierdoN.J.Garcia-RodriguezO.JimenezI.Z.Ocular Symptoms and Signs of" exact="Chikungunya" post="Fever in Puerto RicoP. R. Health Sci. J.201837838729905918 187.MahendradasP.ShettyR.MalathiJ.MadhavanH.N.Chikungunya"/>
  <result pre="chikungunya virus in saliva and urineVirol. J.20161310210.1186/s12985-016-0556-927306056 196.Contopoulos-IoannidisD.Newman-LindsayS.ChowC.LaBeaudA.D.Mother-to-child transmission of" exact="Chikungunya" post="virus: A systematic review and meta-analysisPLoS Negl. Trop. Dis.20181212010.1371/journal.pntd.000651029897898"/>
  <result pre="meta-analysisPLoS Negl. Trop. Dis.20181212010.1371/journal.pntd.000651029897898 197.GérardinP.BarauG.MichaultA.BintnerM.RandrianaivoH.ChokerG.LengletY.TouretY.BouveretA.GrivardP.et al.Multidisciplinary Prospective Study of Mother-to-Child" exact="Chikungunya" post="Virus Infections on the Island of La RéunionPLoS Med.20085e6010.1371/journal.pmed.005006018351797"/>
  <result pre="Island of La RéunionPLoS Med.20085e6010.1371/journal.pmed.005006018351797 198.TouretY.RandrianaivoH.MichaultA.SchuffeneckerI.KauffmannE.LengletY.BarauG.FourmaintrauxA.Early maternal-fetal transmission of the" exact="Chikungunya" post="virusPresse Med.2006351656165810.1016/S0755-4982(06)74874-617086120 199.GrivardP.Le RouxK.LaurentP.FianuA.PerrauJ.GiganJ.HoarauG.GrondinN.StaikowskyF.FavierF.et al.Molecular and serological diagnosis of"/>
  <result pre="Chikungunya virusPresse Med.2006351656165810.1016/S0755-4982(06)74874-617086120 199.GrivardP.Le RouxK.LaurentP.FianuA.PerrauJ.GiganJ.HoarauG.GrondinN.StaikowskyF.FavierF.et al.Molecular and serological diagnosis of" exact="Chikungunya" post="virus infectionPathol. Biol.20075549049410.1016/j.patbio.2007.07.00217920211 200.Prata-BarbosaA.Cleto-YamaneT.L.RobainaJ.R.GuastavinoA.B.de Magalhães-BarbosaM.C.BrindeiroR.D.M.MedronhoR.A.da CunhaA.J.L.A.Co-infection with Zika and"/>
  <result pre="diagnosis of Chikungunya virus infectionPathol. Biol.20075549049410.1016/j.patbio.2007.07.00217920211 200.Prata-BarbosaA.Cleto-YamaneT.L.RobainaJ.R.GuastavinoA.B.de Magalhães-BarbosaM.C.BrindeiroR.D.M.MedronhoR.A.da CunhaA.J.L.A.Co-infection with" exact="Zika" post="and Chikungunya viruses associated with fetal death—A case reportInt."/>
  <result pre="Chikungunya virus infectionPathol. Biol.20075549049410.1016/j.patbio.2007.07.00217920211 200.Prata-BarbosaA.Cleto-YamaneT.L.RobainaJ.R.GuastavinoA.B.de Magalhães-BarbosaM.C.BrindeiroR.D.M.MedronhoR.A.da CunhaA.J.L.A.Co-infection with Zika and" exact="Chikungunya" post="viruses associated with fetal death—A case reportInt. J. Infect."/>
  <result pre="fetal demise in miceSci. Transl. Med.201810eaao709010.1126/scitranslmed.aao709029386359 203.BandeiraA.C.CamposG.S.RochaV.F.D.SouzaB.S.D.F.SoaresM.B.P.OliveiraA.A.de AbreuY.C.MenezesG.S.SardiS.I.Prolonged shedding of" exact="Chikungunya" post="virus in semen and urine: A new perspective for"/>
  <result pre="public health concern?PLOS Biol.201917e300013010.1371/journal.pbio.300013030668574 206.WHO Guidelines on Clinical Management of" exact="Chikungunya" post="FeverAvailable online: http://www.who.int/iris/handle/10665/205178(accessed on 19 February 2019) 207.SilvaJ.V.J.Ludwig-BegallL.F.Oliveira-FilhoE.F.D.OliveiraR.A.S.Durães-CarvalhoR.LopesT.R.R.SilvaD.E.A.GilL.H.V.G.A scoping"/>
  <result pre="online: http://www.who.int/iris/handle/10665/205178(accessed on 19 February 2019) 207.SilvaJ.V.J.Ludwig-BegallL.F.Oliveira-FilhoE.F.D.OliveiraR.A.S.Durães-CarvalhoR.LopesT.R.R.SilvaD.E.A.GilL.H.V.G.A scoping review of" exact="Chikungunya" post="virus infection: Epidemiology, clinical characteristics, viral co-circulation complications, and"/>
  <result pre="PedrosaC.et al.Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits" exact="Chikungunya" post="Virus ReplicationAntimicrob. Agents Chemother.201863e01389-1810.1128/AAC.01389-1830455237 210.FrancoE.J.RodriquezJ.L.PomeroyJ.J.HanrahanK.C.BrownA.N.The effectiveness of antiviral agents"/>
  <result pre="in Patients With Early Persistent Musculoskeletal Pain and Arthritis Following" exact="Chikungunya" post="Virus InfectionArthritis Rheumatol.20146631932610.1002/art.3822124504804 212.de LamballerieX.NinoveL.CharrelR.N.Antiviral treatment of chikungunya virus"/>
  <result pre="Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against" exact="Chikungunya" post="VirusCell Host Microbe201518869510.1016/j.chom.2015.06.00926159721 216.Reyes-SandovalA.51 years in of Chikungunya clinical"/>
  <result pre="Activity against Chikungunya VirusCell Host Microbe201518869510.1016/j.chom.2015.06.00926159721 216.Reyes-SandovalA.51 years in of" exact="Chikungunya" post="clinical vaccine development: A historical perspectiveHum. Vaccin. Immunother.201910.1080/21645515.2019.157414930735447 217.PlanteK.WangE.PartidosC.D.WegerJ.GorchakovR.TsetsarkinK.BorlandE.M.PowersA.M.SeymourR.StinchcombD.T.et"/>
  <result pre="clinical vaccine development: A historical perspectiveHum. Vaccin. Immunother.201910.1080/21645515.2019.157414930735447 217.PlanteK.WangE.PartidosC.D.WegerJ.GorchakovR.TsetsarkinK.BorlandE.M.PowersA.M.SeymourR.StinchcombD.T.et al.Novel" exact="Chikungunya" post="Vaccine Candidate with an IRES-Based Attenuation and Host Range"/>
  <result pre="an IRES-Based Attenuation and Host Range Alteration MechanismPLoS Pathog.20117e100214210.1371/journal.ppat.100214221829348 218.WangE.KimD.Y.WeaverS.C.FrolovI.Chimeric" exact="Chikungunya" post="Viruses Are Nonpathogenic in Highly Sensitive Mouse Models but"/>
  <result pre="LamballerieX.Random Codon Re-encoding Induces Stable Reduction of Replicative Fitness of" exact="Chikungunya" post="Virus in Primate and Mosquito CellsPLoS Pathog.20139e100317210.1371/journal.ppat.100317223436995 220.AcheeN.L.GriecoJ.P.VatandoostH.SeixasG.PintoJ.Ching-NGL.MartinsA.J.JuntarajumnongW.CorbelV.GouagnaC.et al.Alternative"/>
  <result pre="2 Examples of tissue and cell tropism of chikungunya virus." exact="Chikungunya" post="virus (CHIKV) infected cells in skin (A); skeletal muscle"/>
  <result pre="[70] Loxodonta africana Elephant Specific antibodies [70] viruses-11-00175-t002_Table 2Table 2" exact="Chikungunya" post="virus (CHIKV) RNA detection in biological fluids in viremic"/>
 </snippets>
</snippetsTree>
